Cite
26-LB: Exenatide and Renal Outcomes in Patients with Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter, Randomized, Parallel Study.
MLA
Wang, Xiangyu, et al. “26-LB: Exenatide and Renal Outcomes in Patients with Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter, Randomized, Parallel Study.” Diabetes, vol. 69, June 2020, p. N.PAG. EBSCOhost, https://doi.org/10.2337/db20-26-LB.
APA
Wang, X., Zhang, Q., Guan, M., Sheng, S., Mo, W., Zou, M., Li, J., Bi, J., Tang, X., He, J., Xu, G., Li, P., Zhang, H., & Xue, Y. (2020). 26-LB: Exenatide and Renal Outcomes in Patients with Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter, Randomized, Parallel Study. Diabetes, 69, N.PAG. https://doi.org/10.2337/db20-26-LB
Chicago
Wang, Xiangyu, Qian Zhang, Meiping Guan, Shuyue Sheng, Wei Mo, Mengchen Zou, Jimin Li, et al. 2020. “26-LB: Exenatide and Renal Outcomes in Patients with Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter, Randomized, Parallel Study.” Diabetes 69 (June): N.PAG. doi:10.2337/db20-26-LB.